Protalix BioTherapeutics (PLX) Change in Inventory (2010 - 2026)

Protalix BioTherapeutics has reported Change in Inventory for 17 years, with the latest figure at $1.8 million in Q2 2026.

• On a quarterly basis, Change in Inventory rose 11.88% year-over-year to $1.8 million in Q2 2026; TTM through Jun 2026 was $11.2 million, a 2608.98% increase from a year earlier, with the FY2025 full-year figure at $4.5 million, up 104.09% from the prior year.
• Change in Inventory was $1.8 million for Q2 2026 at Protalix BioTherapeutics, down from $4.7 million in the prior quarter.
• The five-year high for Change in Inventory was $4.7 million in Q1 2026, with the low at -$3.5 million in Q3 2024.
• Average Change in Inventory over 5 years is $796555.6, with a median of $874500.0 recorded in 2025.
• The sharpest annual moves came in 2023 and 2026: Change in Inventory plunged 667.82% in 2023, then surged 373.17% in 2026.
• Over 5 years, Change in Inventory stood at $2.2 million in 2022, then slumped by 213.2% to -$2.5 million in 2023, then surged by 259.34% to $4.0 million in 2024, then rose by 10.63% to $4.5 million in 2025, then tumbled by 59.37% to $1.8 million in 2026.
• The last three Change in Inventory figures came in at $1.8 million (Q2 2026), $4.7 million (Q1 2026), and $4.5 million (Q4 2025), per Business Quant data.